Treatment.com AI Inc. (TREIF)
| Previous Close | 0.5270 |
| Open | 0.5343 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 0.4893 - 0.5500 |
| 52 Week Range | 0.0210 - 1.1940 |
| Volume | |
| Avg. Volume | 6,005 |
| Market Cap | 20.408M |
| Beta (5Y Monthly) | -0.22 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.1600 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
GlobeNewswireRepeat: Treatment.com AI Announces New Additions to its Medical Education Suite (MES)
VANCOUVER, British Columbia, April 17, 2024 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (the “ Company ” or “ Treatment ”) is excited to announce two new solutions, (1) AI Patient and (2) AI Doctor in a Pocket, to augment its Medical Education Suite (“ MES ”) designed to educate the next generation of healthcare providers. Treatment’s MES enhances the entire continuum of clinical content education, from simple introductory patient interactions to more advanc
- GlobeNewswire
Treatment.com AI Announces New Additions to its Medical Education Suite (MES)
VANCOUVER, British Columbia, April 17, 2024 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (the “ Company ” or “ Treatment ”) is excited to announce two new solutions, (1) AI Patient and (2) AI Doctor in a Pocket, to augment its Medical Education Suite (“ MES ”) designed to educate the next generation of healthcare providers. Treatment’s MES enhances the entire continuum of clinical content education, from simple introductory patient interactions to more advanc
- GlobeNewswire
Treatment.com AI partners with aiXplain Inc. to extend access to its Global Library of Medicine (GLM)
VANCOUVER, British Columbia, April 10, 2024 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (“Treatment”) is pleased to announce it has signed a Collaborative Agreement with aiXplain, Inc. (“aiXplain”) to enable greater access to Treatment’s proprietary Global Library of Medicine (“GLM”) by contributing to aiXplain’s ever-growing dynamic Artificial Intelligence (AI) marketplace. Treatment has partnered with aiXplain, the industry’s first no-code/low-code integra
